James W. Elrod

Filings by James W. Elrod span 2 companies, the busiest being King Pharmaceuticals Inc and Tivity Health, Inc. Over a trading history stretching from 20 March 2006 to 3 March 2011, the count stands at 22 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

On 7 March 2011 came the latest disclosure, a share grant in Tivity Health, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.